Jialiang Wang

3.8k total citations · 1 hit paper
81 papers, 2.8k citations indexed

About

Jialiang Wang is a scholar working on Molecular Biology, Immunology and Biomedical Engineering. According to data from OpenAlex, Jialiang Wang has authored 81 papers receiving a total of 2.8k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Molecular Biology, 18 papers in Immunology and 17 papers in Biomedical Engineering. Recurrent topics in Jialiang Wang's work include RNA Interference and Gene Delivery (12 papers), Immunotherapy and Immune Responses (12 papers) and Nanoplatforms for cancer theranostics (9 papers). Jialiang Wang is often cited by papers focused on RNA Interference and Gene Delivery (12 papers), Immunotherapy and Immune Responses (12 papers) and Nanoplatforms for cancer theranostics (9 papers). Jialiang Wang collaborates with scholars based in China, United States and Saint Kitts and Nevis. Jialiang Wang's co-authors include Bruce A. Sullenger, Jeremy N. Rich, Justin D. Lathia, Tianmeng Sun, Rebekah R. White, Anita B. Hjelmeland, Timothy P. Wakeman, Xiao-Fan Wang, Jinping Ou and Siqi Ding and has published in prestigious journals such as Advanced Materials, Biomaterials and Cancer Cell.

In The Last Decade

Jialiang Wang

76 papers receiving 2.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A Tumor Microenvironments‐Adapted Polypeptide Hydrogel/Nanogel Composite Boosts Antitumor Molecularly Targeted Inhibition and Immunoactivation

2022 145 citations Jialiang Wang, Ge Zhu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jialiang Wang China	27	1.1k	578	523	449	283	81	2.8k
Li Cui China	36	1.5k 1.3×	354 0.6×	498 1.0×	644 1.4×	340 1.2×	176	4.3k
Yali Chen China	41	2.5k 2.2×	347 0.6×	634 1.2×	606 1.3×	484 1.7×	139	5.4k
Ming Shen China	35	1.2k 1.1×	642 1.1×	777 1.5×	575 1.3×	217 0.8×	175	3.7k
Jing Ruan China	29	1.2k 1.0×	290 0.5×	1.7k 3.2×	513 1.1×	231 0.8×	96	3.6k
Jun Huang China	36	1.5k 1.3×	505 0.9×	898 1.7×	911 2.0×	293 1.0×	150	4.4k
Huijun Zhu China	34	1.7k 1.5×	665 1.2×	347 0.7×	573 1.3×	374 1.3×	135	4.5k
Jianhua Wang China	22	682 0.6×	699 1.2×	722 1.4×	213 0.5×	372 1.3×	106	2.9k
Rui Liu China	26	1.0k 0.9×	145 0.3×	532 1.0×	633 1.4×	266 0.9×	97	2.8k
Jiahui Zhang China	26	1.0k 0.9×	374 0.6×	398 0.8×	382 0.9×	400 1.4×	128	2.5k
Yao Xiao China	28	1.1k 1.0×	258 0.4×	278 0.5×	521 1.2×	160 0.6×	102	2.2k

Countries citing papers authored by Jialiang Wang

Since Specialization

Citations

This map shows the geographic impact of Jialiang Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jialiang Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jialiang Wang more than expected).

Fields of papers citing papers by Jialiang Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jialiang Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jialiang Wang. The network helps show where Jialiang Wang may publish in the future.

Co-authorship network of co-authors of Jialiang Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jialiang Wang. A scholar is included among the top collaborators of Jialiang Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jialiang Wang. Jialiang Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Li, Jiaxuan, Kuirong Mao, Xiandi Meng, et al.. (2025). Injectable hydrogel-assisted local lipopolysaccharide delivery improves immune checkpoint blockade therapy. Acta Biomaterialia. 194. 153–168. 4 indexed citations

Li, He, Xiuxiu Cong, Jialiang Wang, et al.. (2025). Cationic lipid-modified PEG-PLGA nanoparticles facilitate effective dendritic cell reprogramming to alleviate T cell-mediated autoimmunity in EAE. Biomaterials. 327. 123784–123784.

Zhang, Wei, Hao Zhou, Min Yang, et al.. (2025). Adipose-derived soluble fractions activated bioink promotes cutaneous repair and regeneration via mobilizing endogenous reparative cells. Chemical Engineering Journal. 524. 168542–168542.

Wang, Jialiang, Haitian Fu, Wenjin Li, et al.. (2024). A liver-targeting magnetic iron oxide nanoparticle-based dual-modality probe for PET/MR imaging of liver tumor. Colloids and Surfaces A Physicochemical and Engineering Aspects. 692. 134002–134002. 7 indexed citations

Mao, Kuirong, Jialiang Wang, Yong‐Guang Yang, et al.. (2024). Cationic nanoparticles-based approaches for immune tolerance induction in vivo. Journal of Controlled Release. 366. 425–447. 6 indexed citations

Zhang, Yuning, He Li, Xue Gao, et al.. (2023). Co-delivery of vitamin D3 and Lkb1 siRNA by cationic lipid-assisted PEG-PLGA nanoparticles to effectively remodel the immune system in vivo. Biomaterials Science. 11(17). 5931–5941. 4 indexed citations

Wang, Jialiang, Xiaoyu Zhang, Dongmei Chen, et al.. (2023). Blockage of CacyBP inhibits macrophage recruitment and improves anti-PD-1 therapy in hepatocellular carcinoma. Journal of Experimental & Clinical Cancer Research. 42(1). 303–303. 10 indexed citations

Wang, Jialiang, et al.. (2023). Advances in dendritic cell targeting nano-delivery systems for induction of immune tolerance. Frontiers in Bioengineering and Biotechnology. 11. 1242126–1242126. 17 indexed citations

Wang, Jialiang, et al.. (2023). Do oral antidiabetic medications alter the risk of Parkinson’s disease? An updated systematic review and meta-analysis. Neurological Sciences. 44(12). 4193–4203. 7 indexed citations

10.

Meng, Xiandi, Kuirong Mao, Hongmei Chen, et al.. (2023). Maleimide as the PEG end-group promotes macrophage-targeted drug delivery of PEGylated nanoparticles in vivo by enhancing interaction with circulating erythrocytes. Biomaterials. 300. 122187–122187. 20 indexed citations

11.

Liu, Chao, Jinjuan Fu, Ken Chen, et al.. (2021). Increased AT1 receptor expression mediates vasoconstriction leading to hypertension in Snx1−/− mice. Hypertension Research. 44(8). 906–917. 13 indexed citations

12.

Hu, Yuanyuan, Guanhua Zhao, Fawen Yin, et al.. (2021). Effects of roasting temperature and time on aldehyde formation derived from lipid oxidation in scallop (Patinopecten yessoensis) and the deterrent effect by antioxidants of bamboo leaves. Food Chemistry. 369. 130936–130936. 68 indexed citations

13.

Chen, Hongmei, Xiuxiu Cong, Chenxi Wu, et al.. (2020). Intratumoral delivery of CCL25 enhances immunotherapy against triple-negative breast cancer by recruiting CCR9 ⁺ T cells. Science Advances. 6(5). eaax4690–eaax4690. 70 indexed citations

14.

Chen, Shuo, Xinquan Wang, Gengze Wu, et al.. (2020). Exposure to maternal diabetes induces endothelial dysfunction and hypertension in adult male rat offspring. Microvascular Research. 133. 104076–104076. 14 indexed citations

15.

Huang, Yanlin, Gang Ning, Lubiao Chen, et al.. (2019). <p>Promising diagnostic and prognostic value of E2Fs in human hepatocellular carcinoma</p>. Cancer Management and Research. Volume 11. 1725–1740. 43 indexed citations

16.

Wang, Jialiang, et al.. (2017). Nrf2 suppresses the function of dendritic cells to facilitate the immune escape of glioma cells. Experimental Cell Research. 360(2). 66–73. 60 indexed citations

17.

Yao, Yong‐Gang, Wei Wang, Meixiang Li, et al.. (2016). Curcumin Exerts its Anti-hypertensive Effect by Down-regulating the AT1 Receptor in Vascular Smooth Muscle Cells. Scientific Reports. 6(1). 25579–25579. 60 indexed citations

18.

Hover, Laura D., Philip Owens, Jialiang Wang, et al.. (2015). Bone morphogenetic protein signaling promotes tumorigenesis in a murine model of high-grade glioma. Neuro-Oncology. 18(7). 928–938. 26 indexed citations

19.

Ai, Yongxing, Jialiang Wang, Robert E. Johnson, et al.. (2011). A novel ubiquitin binding mode in the S. cerevisiae translesion synthesisDNA polymerase η. Molecular BioSystems. 7(6). 1874–1882. 8 indexed citations

20.

Wang, Jialiang, Hanbing An, Marty W. Mayo, Albert S. Baldwin, & Wendell G. Yarbrough. (2007). LZAP, a Putative Tumor Suppressor, Selectively Inhibits NF-κB. Cancer Cell. 12(3). 239–251. 81 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact